Discovery of MRSA active antibiotics using primary sequence from the human microbiome.
Nat Chem Biol
; 12(12): 1004-1006, 2016 Dec.
Article
em En
| MEDLINE
| ID: mdl-27748750
ABSTRACT
Here we present a natural product discovery approach, whereby structures are bioinformatically predicted from primary sequence and produced by chemical synthesis (synthetic-bioinformatic natural products, syn-BNPs), circumventing the need for bacterial culture and gene expression. When we applied the approach to nonribosomal peptide synthetase gene clusters from human-associated bacteria, we identified the humimycins. These antibiotics inhibit lipid II flippase and potentiate ß-lactam activity against methicillin-resistant Staphylococcus aureus in mice, potentially providing a new treatment regimen.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Produtos Biológicos
/
Staphylococcus aureus Resistente à Meticilina
/
Descoberta de Drogas
/
Microbiota
/
Antibacterianos
Limite:
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article